These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2644145)

  • 21. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
    Haffner SM; Bowsher RR; Mykkänen L; Hazuda HP; Mitchell BD; Valdez RA; Gingerich R; Monterossa A; Stern MP
    Diabetes; 1994 Dec; 43(12):1490-3. PubMed ID: 7958504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range.
    Lorenzo C; Hanley AJ; Rewers MJ; Haffner SM
    Acta Diabetol; 2014 Aug; 51(4):617-23. PubMed ID: 24532116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
    Haffner SM; Gonzalez C; Mykkänen L; Stern M
    Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.
    Mykkänen L; Haffner SM; Kuusisto J; Pyörälä K; Hales CN; Laakso M
    Diabetologia; 1995 Oct; 38(10):1176-82. PubMed ID: 8690169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinsulin as a marker for the development of NIDDM in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstrom RW; Fujimoto WY
    Diabetes; 1995 Feb; 44(2):173-9. PubMed ID: 7859937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance.
    Hanson U; Persson B; Hartling SG; Binder C
    Diabetes Care; 1996 Jan; 19(1):17-20. PubMed ID: 8720527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus.
    Røder ME; Vaag A; Hartling SG; Dinesen B; Lanng S; Beck-Nielsen H; Binder C
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2359-63. PubMed ID: 7629230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
    Matsumoto K; Akazawa S; Abiru N; Yano M; Ishibasi M; Uotani S; Matsuo H; Kawasaki E; Yamasaki H; Yamamoto H
    Diabetes Res Clin Pract; 1994 Dec; 26(2):129-35. PubMed ID: 7705194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects.
    Beer SF; O'Rahilly S; Spivey RS; Hales CN; Turner RC
    Diabetes Res; 1990 Jun; 14(2):51-4. PubMed ID: 2134213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity--clinical research center study.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstrom RW; Fujimoto WY
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1399-406. PubMed ID: 7714116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of conventional and intensified insulin therapy on free-insulin profiles and glycemic control in NIDDM.
    Lindström TH; Arnqvist HJ; von Schenck HH
    Diabetes Care; 1992 Jan; 15(1):27-34. PubMed ID: 1737539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersecretion of proinsulin does not explain the hyperinsulinaemia of patients with liver cirrhosis.
    Ballmann M; Hartmann H; Deacon CF; Schmidt WE; Conlon JM; Creutzfeldt W
    Clin Endocrinol (Oxf); 1986 Oct; 25(4):351-61. PubMed ID: 3304724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.
    Kasperska-Czyźykowa T; Heding LG; Czyzyk A
    Diabetologia; 1983 Dec; 25(6):506-9. PubMed ID: 6363178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.